Retatrutide GLP-3 16mg

Retatrutide (LY3437943) is a groundbreaking synthetic peptide that functions as a triple agonist, simultaneously targeting the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). By mimicking the effects of three key hormones involved in metabolic regulation and appetite control, Retatrutide offers a comprehensive approach to weight loss and metabolic health. This unique mechanism positions it as a promising candidate for the treatment of obesity and related metabolic disorders, with the potential to deliver superior results compared to traditional single or dual agonist therapies.